Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Vamstar logo — Artificial Intelligence for Commercial Outcomes in Pharma an...

Vamstar

Artificial Intelligence for Commercial Outcomes in Pharma and MedTech

Founded 2019 United Kingdom London, United Kingdom 71 employees Series A Total: $8.28M AI, Analytics +4

General Information

Company Name Vamstar
Founded Year 2019
Location United Kingdom London, United Kingdom +3
Founders / Decision Makers
Team member Team member
Employees 71
Industries AI, Analytics, B2B +3
Funding Stage Series A
Social

Get notified when Vamstar moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Product Launch Sep 01, 2026

Vamstar launched Polaris, an agentic AI solution for clause monitoring, designed to help MedTech manufacturers prevent margin erosion from uncollected contracted value.

Get alerts when Vamstar shows new signals

About Vamstar

Vamstar, founded in 2019, stands at the forefront of integrating Artificial Intelligence with commercial functionalities in the Pharmaceutical and MedTech industries. Headquartered in the United Kingdom, the company leverages agentic AI to optimize processes such as tendering, pricing, market access, and contract management.

Positioned as a strategic partner, Vamstar caters to the top global 100 MedTech, Pharma, and Biotech companies, embedding AI solutions within workflows to produce measurable margin impacts. Their approach exemplifies the potential of vertical-specific AI solutions in delivering enhanced commercial outcomes.

The company secured a $6.46M Series A investment on 01 June 2022 from notable investors such as Alpha Intelligence Capital, Antler, b2venture, and DFF Ventures. With its innovative AI-driven solutions, Vamstar is poised for growth within the B2B, Analytics, and Marketplaces sectors.

Taxonomy: Agentic AI, Healthcare Marketplace, Data Automation, Tendering and Pricing, Market Access, Contract Management, Real-Time Analytics, Demand Aggregation, Procurement and Sourcing, Digital Health, Supply Chain Platform, Value Based Procurement, Outcomes Based Contracting, Medical Technologies

Services & Products

Agentic AI Solutions
Pricing Co-Pilot
Value AI
Contract Management Automation
Market Intelligence

Target Customers

Pharmaceutical Companies Biotechnology Organizations Medical Device Companies MedTech Firms Private Equity Firms

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor
•••• •••• 		01 Jun 2022
Unknown •••••• - 01 Nov 2021
Seed •••••• 3
Investor Investor Investor
01 Feb 2021
Grant •••••• - 01 Jun 2020
Seed •••••• 1
Investor
01 Oct 2019

Vamstar Alternatives & Competitors

View All Alternatives
Vamstar vs
dSilo.AI
dSilo.AI United States

dSilo is the Agentic AI platform that unlocks intelligence from silos of contracts and financial dat...

Seed
161 employees
AI, Enterprise Software
Compare Vamstar vs dSilo.AI
Vamstar vs
Payflows
Payflows France

Innovative FinTech platform automating finance workflows, reducing costs, and optimizing operational...

Series A
45 employees
Financial Services, Fintech
Compare Vamstar vs Payflows
Vamstar vs
SEQUESTO
SEQUESTO Belgium

Agentic OS for exceptional commercial teams

21 employees
Also compare with: Vamstar vs Unique Unique View all alternatives

FAQ About Vamstar

Artificial Intelligence for Commercial Outcomes in Pharma and MedTech
Vamstar was founded in 2019.
Vamstar is headquartered in London, United Kingdom.
Vamstar operates in the following industries: AI, Analytics, B2B, Marketplaces, Pharmaceutical, Machine Learning.
Vamstar has approximately 71 employees.
Vamstar has completed 5 funding rounds, raising a total of $8.28M. The latest funding stage is Series A.
Vamstar offers: Agentic AI Solutions, Pricing Co-Pilot, Value AI, Contract Management Automation, Market Intelligence.
Top alternatives and competitors to Vamstar include dSilo.AI, Payflows, SEQUESTO, Unique, Salesloft. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vamstar and dSilo.AI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vamstar and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy